NCT06667141
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06667141
Title Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acrivon Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Cancer Care RECRUITING Phoenix Arizona 85016 United States Details
Precision NextGen Oncology & Research Center RECRUITING Beverly Hills California 90212 United States Details
Hoag Memorial Hospital Presbyterian RECRUITING Newport Beach California 92663 United States Details
Denver Health One RECRUITING Denver Colorado 80218 United States Details
Florida Cancer Specialist RECRUITING Sarasota Florida 34232 United States Details
Beth Israel Deaconess Medical Center RECRUITING Boston Massachusetts 02215 United States Details
University of Michigan RECRUITING Ann Arbor Michigan 48109 United States Details
Roswell Park Comprehensive Cancer Center RECRUITING Buffalo New York 14203 United States Details
Montefiore Medical Centre RECRUITING The Bronx New York 10461 United States Details
Carolina BioOncology Institute RECRUITING Huntersville North Carolina 28078 United States Details
Rhode Island Hospital RECRUITING Providence Rhode Island 02903 United States Details
Tennesse Oncology RECRUITING Franklin Tennessee 37067 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77054 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
Next Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field